Inside Health Policy

InsideHealthPolicy.com is a subscription-based online service that provides daily news updates and newsletters from Inside Washington Publishers, a company that has been delivering insider information from Washington, DC for over 30 years. The site is regularly refreshed with articles from our newsletter team, including Health Exchange Alert, Inside CMS, and FDA Week. It also features daily Short Takes and curated documents, all organized in a fully searchable archive. Users can explore dedicated sections on various topics such as health reform, Congress, Medicare, drug policies, and food safety. Additionally, subscribers receive a Morning Headlines email alert every business day, ensuring they stay informed about important news right from the start of their day.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#1070123

United States

#252802

Law and Government/Government

#4716

Traffic sources

Monthly visitors

Articles

BMA Pushes Back As GOP Senators Broach MA Cuts In Reconciliation Talks

2 days ago | insidehealthpolicy.com | Sigi Ris |Amy Lotven

With Republican senators now open to cuts to Medicare, and some already suggesting that upcoding by Medicare Advantage plans should be stemmed, the lobby representing MA plans warns that going after the program would “break a promise to the more than 34 million seniors who rely on it.”
House Passes SUPPORT Act Amid Dem Concerns About SAMHSA Cuts

3 days ago | insidehealthpolicy.com | Sigi Ris

In a bipartisan vote Wednesday (June 4), the House passed legislation reauthorizing the signature 2018 opioid response SUPPORT Act, which expired in 2023 and has yet to receive full reauthorization.
Divisive State AI Regulation Freeze Appears Unlikely To Pass

3 days ago | insidehealthpolicy.com | Christian Robles |Sigi Ris

GOP lawmakers appear poised to remove a controversial proposal to bar states from implementing artificial intelligence regulations -- including those that affect health care stakeholders -- for a decade from the budget reconciliation bill as Republican and Democratic lawmakers alike come out against the provision.
State Directed Payments Sticking Point Among GOP Senators

3 days ago | insidehealthpolicy.com | Dorothy Mills-Gregg |Amy Lotven |Sigi Ris

Several GOP senators who have raised concerns about the House-passed reconciliation bill say they support Medicaid work requirements, but are split when it comes to the freeze on provider taxes, with Missouri Senator Josh Hawley suggesting a moratorium would harm rural hospitals while others argue the House didn’t go far enough to stop the practice and warn the provision must be retroactive to prevent state legislatures from trying to squeeze in increases before it goes into effect.
Provider Taxes, State Directed Payments Sticking Points Among GOP Senators

4 days ago | insidehealthpolicy.com | Dorothy Mills-Gregg |Amy Lotven |Sigi Ris

Several GOP senators who have raised concerns about the House-passed reconciliation bill say they support Medicaid work requirements, but are split when it comes to the freeze on provider taxes, with Missouri Senator Josh Hawley suggesting a moratorium would harm rural hospitals while others argue the House didn’t go far enough to stop the practice and warn the provision must be retroactive to prevent state legislatures from trying to squeeze in increases before it goes into effect.
Teledentists Ask DOJ Task Force To Oppose State Laws Requiring In-Person Visits

4 days ago | insidehealthpolicy.com | Cara Smith

Teledentistry stakeholders are urging the Trump administration’s Anticompetitive Regulations Task Force to oppose state laws that establish in-person requirements to access virtual dental care, claiming the restrictive legislation damages the telehealth business model.
Trump’s MFN Push Sparks Concerns For Generics, Biosimilars Makers

5 days ago | insidehealthpolicy.com | Maaisha Osman

The Trump administration’s push to revive the controversial “most favored nation” (MFN) pricing policy -- alongside ongoing uncertainty around tariffs and Medicare drug price negotiations -- is creating deep uncertainty for the future of generic and biosimilar drug development in the United States, Association for Accessible Medicines (AAM) President and CEO John Murphy told Inside Health Policy in a Monday (June 2) interview.
Oz: CMS IT Infrastructure Will Help States Implement Medicaid Work Requirements

5 days ago | insidehealthpolicy.com | Christian Robles |Dorothy Mills-Gregg

As part of CMS’ sweeping and fast push to modernize health IT systems, CMS Administrator Mehmet Oz told Politico his agency will help states manage the administrative burden that GOP-backed national Medicaid work requirements would pose with the agency’s growing IT infrastructure.
FDA Effectively Scraps LDT Rule By Not Appealing Court Ruling

5 days ago | insidehealthpolicy.com | Maaisha Osman

FDA’s decision not to appeal a federal court ruling that invalidated its attempt to regulate laboratory-developed tests (LDTs) under the medical device framework signals the Trump administration’s intention not to defend the rule -- a move that falls in line with the previous Trump administration’s move to block FDA from regulating LDTs.
Advocates Blast Proposed Cuts To NIH, CDC Research Programs

5 days ago | insidehealthpolicy.com | Maaisha Osman

HHS is requesting $27.5 billion for the National Institutes of Health and $4.3 billion for the Centers for Disease Control and Prevention in its detailed fiscal 2026 budget request to Congress released Friday (May 30) -- mirroring the Trump administration’s “skinny budget” proposal earlier in the month for a roughly 40% cut to both agencies -- while emphasizing certain chronic disease research and making deep reductions to global health and emergency preparedness programs.